The Laryngoscope · 2014 · 58 citations · 12 references
MedicineOncologyHead OncologyNeck OncologyOral OncologyHuman Papillomavirus InfectionHypopharyngeal CancerNeck PathologyOncogenic VirusesOral Cavity CancerOropharyngeal CancerDna In Situ HybridizationFormalin-fixed Paraffin-embedded Tissue AnalysisHuman Papillomavirus-related DiseaseOral Cavity PathologyOropharyngeal LesionsQuantitative In Situ HybridizationQuantitative Polymerase Chain Reaction AssaysSquamous Cell Carcinoma Pathology
OBJECTIVES/HYPOTHESIS: The incidence of human papillomavirus (HPV)-driven disease beyond the oropharynx varies greatly in the reported literature. STUDY DESIGN: Case series. METHODS: Two hundred twenty-one samples were strictly classified to the subsites of oral cavity, larynx, or hypopharynx at the time of primary surgery. Formalin-fixed paraffin-embedded samples were subjected to a validated, tiered, diagnostic algorithm of p16 immunohistochemistry, high-risk HPV in situ hybridization, and quantitative polymerase chain reaction for HPV E6 DNA. An additional 60 oropharyngeal cases acted as an internal biological control. RESULTS: An incidence of 4% of HPV-driven cases was observed across the subsites outside the oropharynx compared to 70% of tumors confined within it. CONCLUSIONS: This is the first reporting of a broad range of nonoropharyngeal HPV rates using this validated diagnostic algorithm. It remains unclear whether patients with HPV-driven disease originating outside the oropharynx enjoy the same survival advantage apparent in those patients with oropharyngeal squamous cell carcinomas. LEVEL OF EVIDENCE: 4 Laryngoscope, 124:2739-2744, 2014.
12
Aatur D. Singhi, William H. Westra · Cancer · 2010 · 474 citations · Full text
Survival following primary surgery for oral cancer
S.N. Rogers, James S. Brown, Julia A. Woolgar et al. · Oral Oncology · 2008 · 422 citations
Andrew Schache, Triantafillos Liloglou, Janet M. Risk et al. · Clinical Cancer Research · 2011 · 327 citations · Full text